Home / Filing-delay notices (10-Q) / Allarity Therapeutics, Inc.

1/5Allarity Therapeutics, Inc. (ALLR): Filing-delay notice, quarterly report filed within extension (NT 10-Q)

Filed 2025-08-14 路 Form NT 10-Q 路 Accession 0001213900-25-076643 nano

Market data

Price before filing: $0.9999 (2025-08-13 close, split/dividend-adjusted)
Market cap at flag: $14.4M (2025-08-14) 路 Latest: $14.2M (2026-10-16)

What happened next

WindowALLRSPYvs SPY
30 days+63.0%+2.5%+60.5%2025-09-15
90 days+27.0%+6.3%+20.8%2025-11-12
180 days-7.0%+7.9%-14.9%2026-02-10
1 year+37.0%+21.7%+15.3%2026-08-14

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

What this means

The company filed Form NT 10-Q, telling the SEC it could not file its quarterly report on time, and then filed the report within the 5-day extension. The SEC treats a report filed within the extension as timely, so this is the mildest kind of flag, but the notice itself is a warning sign that investors often react to: something, often the audit or the accounting, took longer than planned.

Status: filed within extension (report filed 2025-08-15) · the SEC treats a report filed within the extension as timely

Why this score: report filed within the extension on 2025-08-15

Read the original filing on SEC.gov →

Not investment advice. Automated summary; verify against the filing.

Get the weekly "Red Flags" newsletter

The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.

Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.

Form not showing? Subscribe on beehiiv →

Newsletter delivered by beehiiv. See our privacy policy.